Aktis Oncology, Inc.
AKTS • NASDAQ
Aktis Oncology, Inc. is a biotechnology company in the healthcare sector trading on NASDAQ, led by CEO Matthew Roden, with a market cap of $838.0M.
Market Cap$838.0M
Employees222.0
CEOMatthew Roden
CountryUnited States of America
Healthcare
Biotechnology
Next EarningsMay 12, 2026 · in a monthQ1 2026
Financials
AKT
Aktis Oncology, Inc. FAQ
Common questions about Aktis Oncology, Inc.
Aktis Oncology, Inc. is scheduled to report earnings for Q1 2026 on May 12, 2026. Analysts estimate revenue of $2.4M.
Aktis Oncology, Inc. has approximately 222 employees.